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Abstract: A comprehensive study on essential oils (EOs) extracted from some  
Mentha suaveolens L. samples, collected in the countryside of Tarquinia, is reported. In this 
study, the procedure for essential oil preparation, in terms of harvesting and extraction time, 
was analyzed in detail for the first time. The GC/MS analysis, carried out on 18 samples, 
revealed that piperitenone oxide (PO), the main essential oils’ chemical constituent, is 
primarily responsible for the related antifungal activity. Nevertheless, EOs with lower PO 
content indicate that other chemicals, such as para-cymenene, may participate in exerting 
OPEN ACCESS
Molecules 2015, 20 9641 
 
 
the EOs’ antifungal effect. Furthermore, the bacterial reverse mutation assay highlighted 
lack of mutagenic effect in all tested samples. Analysis of the results indicated that for higher 
activity, the essential oils should be produced with 3 h maximum hydrodistillation, regardless 
of the harvesting time. Differently, the maximum essential oil yield can be obtained in August 
and the highest piperitenone oxide percentage is obtainable in July. 
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1. Introduction 
Antimicrobial properties of essential oils (EOs) are continuously investigated both in vitro [1,2] and 
in vivo [3,4] against a wide range of pathogenic bacteria and fungi. Among practical uses, the use of EOs 
as feed and food additives for the control of gastrointestinal tract pathogens has been suggested [5–7]. 
In clinical settings, EOs’ topical use is the most promising strategy for both skin and mucous membranes [8]. 
EOs are generally obtained by hydro or steam distillation from various plant sources and, among them, 
the genus Mentha is an important source of basic raw materials [9]. EOs extracted from various plants 
of mint genus have been extensively investigated for their biological and antimicrobial activities. 
However, many of them remain to be thoroughly investigated. In particular, the chemical composition 
of the essential oil extracted from Mentha suaveolens Ehrh is highly variable and depends on several 
factors among which the most important is the easy hybridization of the Mentha species [10–12],  
the harvesting time [13,14], the geographic area [14–25] and the part of the plant extracted [26]. A 
bibliographic survey carried out in Scopus search engine (www.scopus.com, accessed 8 October 2014) 
revealed that 48 individual articles mentioned the words “Mentha suaveolens essential oil” (EOMS) 
although only a 10th actually reported details on the chemical composition.  
As extensively reported by Lawrence and Šarić-Kundalić, M. suaveolens can be classified as 
“spicatae” line on the basis of the inflorescence characters, but for a more detailed classification the 
characterization of monoterpenes (reflecting three major metabolic pathways) contained in the essential 
oil is required [14,19]. 
Recently, we have focused on the extraction of EOs from wild plants of M. suaveolens, collected in 
the Tarquinia countryside [4,27–29] highlighting motivating antimicrobial activities, with a potency 
against Candida albicans similar to that of antifungal drugs [4,27]. The chemical composition of the  
M. suaveolens essential oil from Tarquinia (TEOMS) indicates that, in this region, the plant mostly 
developed carvon metabolic pathways [14], due to the presence of piperitenone oxide (PO) as the major 
component. Based on this consideration, the antimicrobial activity found for TEOMS was mainly ascribed 
to this monoterpene, although deeper investigations are required to ascertain the actual PO mechanism  
of action. Among the different reported EO extraction methods, TEOMS was mainly obtained by 
hydrodistillation, using a Clevenger-type apparatus for 3–4 h. During our research on TEOMS, it was 
observed that, either shortening or extending the hydrodistillation time, a different chemical composition 
of the essential oil could be obtained with some variation in the related biological activity. As a 
consequence, to obtain the optimal chemical composition of TEOMS, two main questions arise: “When 
the plant has to be harvested?” and “How long should the hydrodistillation time be?” 
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Due to weather conditions, difficulties in reaching the M. suaveolens field located in the Tarquinia 
area and the wild growth of the plant, the period to study TEOMS was restricted to the summer season. 
Concerning the second question, a fractional hydrodistillation protocol was applied to assess the optimal 
time of extraction. Herein, in line with our previous studies [4,27], we report a comprehensive study on 
the TEOMS chemical composition and the related antifungal activity. Furthermore, in order to assess 
TEOMS safety, mutagenicity studies were carried out on some representative samples. 
2. Results and Discussion 
2.1. Essential Oil Extraction 
Fresh aerial parts from M. suaveolens were subjected to hydrodistillation and the oil was collected 
at various times (1, 2, 3, 6, 12 and 24 h, Table 1 and Supplemental Material Figure S1) on three different 
days (see Material and Methods Section). The amount of essential oil varied in function of both the 
extraction day and the separation intervals. In August and September, the essential oil yields (0.19% and 
0.18%, respectively) were more than 2.5 times those of July (0.07%, Table 1), nevertheless the oils 
showed similar profiles at various extraction times and on the different days. The highest amounts were 
obtained during the first three extraction phases (1 to 3 h) and the last 12 h of extraction (12 to 24 h). 
Particularly, during the first three hours, about 70%, 54% and 51% of essential oil was extracted in July, 
August and September, respectively. Considering the classical hydrodistillation procedure, always 
reported to be over in three hours [15,16,24] from data reported in Table 1, the extraction yield would 
have been 0.05%, 0.10% and 0.09% for July, August and September, respectively. 
Table 1. Amount of essential oil (grams) over time and relative yield % calculated on the 
fresh plant material.  
h 1 
July August September 
EO (g) Yield % EO (g) Yield % EO (g) Yield % 
1 0.73 0.03 1.67 0.07 1.32 0.05 
2 1.05 0.04 2.14 0.09 2.27 0.09 
3 1.17 0.05 2.58 0.10 2.35 0.09 
6 1.28 0.05 3.09 0.12 2.49 0.10 
12 1.42 0.06 3.63 0.15 2.75 0.11 
24 1.72 0.07 4.76 0.19 4.59 0.18 
1 h = extraction hours. 
2.2. GC/MS EO Analysis 
The GC/MS analysis of the 18 TEOMS samples highlighted the presence of 48 different chemical 
constituents (Supplemental Material Table S2), having different concentrations in the various fractions. 
In general, the most abundant compound was piperitenone oxide (PO), characteristic for the TEOMS 
chemotype. Based on the extraction time, PO percentage reached the maximum during the first three 
hours (J1h, A2h and S3h, Tables 2–4, Supplemental Material Figure S2) to diminish during the last 
three extraction phases (J6h, J12h and J24h) until disappearing in the J24h and A24h extracts. The 
component was particularly abundant in July (87%) and August (77%) samples. 
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Table 2. Chemical composition of TEOMS extracted in July. Values are in % weight rounded 
to the second decimal place. 
# 1 Name 
Sample 2 
J1h J2h J3h J6h J12h J24h 
1 (−)-spathulenol 2.17 8.18 8.99 14.23  18.35 
4 3-octanol 0.18      
5 3-octanol acetate 0.11      
6 α-cadinene  0.24     
7 α-cadinol  0.50 1.75 9.09 10.69 7.62 
8 α-cubebene 0.30 0.31  0.09   
13 β-bourbonene 0.17      
22 borneol 0.12      
23 calamenene 0.58 2.09 2.52 3.75 10.63 4.32 
24 carbitol    0.55  2.36 
25 β-caryophyllene oxide 5.32 13.67 12.65 14.37 5.27 9.24 
26 cinerolone 0.17 0.09    7.71 
27 citronellylacetate    0.63 3.21 5.45 
28 copaene    0.06  0.76 
29 cubenol 0.20  1.92 7.46 6.17 4.24 
31 δ-cadinene    0.12  4.89 
32 demelverine 0.59 0.51 2.18 9.52 43.46 20.28 
34 eucarvone 0.08      
36 gamma-cadinene      0.86 
37 p-cymen-8-ol 0.12      
38 p-menth-1-en-8-ol 0.14      
40 piperitenone oxide 87.25 70.59 65.56 26.03 14.00  
41 tau-cadinol   0.72 1.39  1.37 
42 tau-muurolol  0.18 1.23 2.14  3.29 
46 verbenone 1.29 1.15  2.98 6.56 6.43 
47 veridiflorol 1.21 2.48 2.49 7.59  2.83 
1 # indicate the compound identification number; 2 Samples names were obtained by merging the month first 
letter and extraction time as reported in Table 1. 
Table 3. Chemical composition of TEOMS extracted in August. Values are in % weight 
rounded to the second decimal place. 
# 1 Name 
Sample 2 
A1h A2h A3h A6h A12h A24h 
1 (−)-spathulenol 0.79 1.48 2.47 2.12 0.32  
4 3-octanol 0.73   0.11 0.07  
5 3-octanol acetate 2.08 1.02 0.90    
7 α-cadinol    0.78 0.48 0.09 
8 α-cubebene 5.07 4.36 10.08 3.64 0.45 0.14 
10 α-pharnesene 5.15 8.01 16.54 9.09 2.56 0.37 
11 α-phellandrene 0.11      
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Table 3. Cont. 
# 1 Name 
Sample 2 
A1h A2h A3h A6h A12h A24h 
12 α-pinene 1.84      
14 p-cymenene 0.87 0.33 2.54 7.74 18.24 35.22 
15 β-elemene    0.38 0.07  
16 β-myrcene 1.42      
17 β-ocymene 0.59      
18 β-pharnesene 0.73 1.03 2.29 2.24 0.89 0.18 
19 β-phellandrene 0.42      
20 β-pinene 0.68      
21 bicyclosesquiphellandrene 0.88 0.98 2.37 1.89 0.41  
22 borneol 0.28 0.29 0.39 0.37 0.30 0.20 
23 calamenene 0.44 1.07 1.56 1.33 0.65  
25 β-caryophyllene oxide 0.50 0.32 1.04 8.30 17.25 12.93 
26 cinerolone    23.12 34.49 38.79 
28 copaene    0.79 0.47  
29 cubenol    0.36 0.09 0.04 
30 d-limonene 6.22      
31 δ-cadinene 0.09 0.27 1.07 2.32 1.54 0.44 
32 demelverine 0.13 1.10 3.14 7.46 8.82 5.90 
33 eucalyptol 4.21 0.47     
36 δ-cadinene    0.51 0.26 0.06 
37 p-cymen-8-ol 0.21 0.54 0.66 0.94 0.97 0.55 
39 p-menthone 0.39 0.46 2.63 5.70 5.61 2.25 
40 piperitenone oxide 65.05 77.51 50.01 16.90 2.43  
44 thymol    0.39 0.32 0.24 
46 verbenone 0.27 0.31 0.81 2.47 3.14 2.58 
47 veridiflorol    0.39 0.17  
48 ylangene 0.85 0.43 1.50 0.64   
1 # indicate the compound identification number; 2 Samples names were obtained by merging the month first 
letter and extraction time as reported in Table 1. 
Table 4. Chemical composition of TEOMS extracted in September. Values are in % weight 
rounded to the second decimal place. 
# 1 Name 
Sample 2 
S1h S2h S3h S6h S12h S24h 
1 (−)-spathulenol 3.67 8.95 2.54 3.62 1.69 0.99 
2 (z)-jasmone      0.54 
3 2-caren-10-al     0.32 0.76 
4 3-octanol   3.13 4.74 0.82 0.61 1.19 
5 3-octanol acetate  4.90 2.20 0.15 0.12 0.15 
7 α-cadinol 0.34  0.49 1.73 1.22 0.44 
8 α-cubebene   0.23 1.97 0.96 1.70 
9 α-muurolene 0.09  0.13 0.51 0.58 0.15 
10 α-pharnesene 1.60 10.15 0.11 12.09 6.42 6.31 
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Table 4. Cont. 
# 1 Name 
Sample 1 
S1h S2h S3h S6h S12h S24h 
12 α-pinene      0.83 
14 p-cymenene  0.83  1.09 5.04 26.64 
16 β-myrcene      0.35 
17 β-ocymene      0.25 
18 β-pharnesene 0.30 1.32 0.11 5.46 3.23 0.48 
19 β-phellandrene      0.10 
21 bicyclosesquiphellandrene   0.19 2.33 1.16 0.77 
22 borneol    0.23 0.34 0.14 
23 calamenene 1.68 3.01 1.26 1.87 1.21 0.80 
25 β-caryophyllene oxide 14.16 14.08 6.30 5.77 9.65 6.37 
26 cinerolone 18.82   2.66 13.04 18.96 
28 copaene 0.18 0.21 0.31 1.55 1.67 0.49 
29 cubenol 0.40 1.77 0.70 1.44 0.84 0.18 
30 d-limonene  0.69    4.84 
31 delta-cadinene 0.89  0.14 3.05 3.33 1.25 
32 demelverine 6.23 0.68 1.84 2.46 4.90 5.22 
33 eucalyptol  1.16 0.43   2.24 
35 eugenol 1.42   2.07 3.16 0.55 
37 p-cymen-8-ol 1.67 9.22 0.37 26.77 24.68 4.52 
38 p-menth-1-en-8-ol  0.55 0.20 0.88 0.72 0.22 
39 p-menthone   4.46 1.21 1.57 3.61 
40 piperitenone oxide 38.69 35.64 69.52 13.20 5.53 5.61 
43 terpinen-4-ol   0.16 0.30  0.16 
44 thymol 1.34   0.25 1.04 0.15 
45 trans-2-caren-4-ol    0.20   
46 verbenone 8.11 1.98 2.30 3.68 5.48 2.28 
47 veridiflorol 0.42 1.74 0.99 1.80 0.96 0.28 
48 ylangene    0.83 0.31 0.46 
1 # indicate the compound identification number; 2 Samples names were obtained by merging the month first 
letter and extraction time as reported in Table 1. 
Other constituents are characteristic of the extraction time and become important only starting from 
or after the fourth fractions (6 h). In particularly, in July, demelverine (32), present in all samples, showed 
percentages of about 0.5% to 2.0% in the first three hours (J1h–J3h) of extraction to rapidly grow up to 
more than 43% at 12 h extraction (J12h). The same compound in August increased from about 0.1% 
(A1h) to only 8.8% (A12h). Still in August, p-cymenene and cinerolone were found as characterizing 
compounds for the last fractions (A24h). The first one was always contained in all the samples, 
increasing from about 0.87% (A1h) to a maximum of 35.22% (A24h). Cinerolone was absent in the 
samples collected during the first three hours of extraction (A1h–A3h),while showing high percentage 
in the next three phases, reaching the maximum amount of about 38.8% after 24 h of extraction (A24h). 
A third different composition scenario was found in September, although piperitenone oxide was still 
the most abundant compound, with other randomly distributed components. Medium-high percentages 
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of β-caryophyllene oxide (14.16%) and cinerolone (18.82%) were found after the first hour of extraction 
(S1h). After the 2h extraction (S2h), β-caryophyllene oxide decreased while cinerolone disappeared. 
This last compound appeared again after five hours (S6h) up to the last extraction (S24h), with a 
percentage varying from 2.66% to 18.96%. Other important chemical components, including α-farnesene 
(about 12% in S6h), p-cymenene (more than 26% in S24h) and p-cymen-8-ol (about 25% in the S6h 
and S12h extractions) were also found. Notably, the complexity of the OE chemical composition 
increased from July to September, being sample S24h—with 36 different chemical components out  
of the 48—the most complex one (Table 4 and Supplemental Material Figure S3). GC analyses were 
carried out twice showing reproducible results, nevertheless, no statistical analyses were performed. For 
comparison purposes, Tables 2–4 are also reported as united tables in Supplemental Material Table S3. 
2.3. Antimicrobial Assay  
The in vitro antifungal activity of TEOMS extracted at different times and in different summer months, 
against the reference strain C. albicans ATCC 10231, is reported in Table 5. The results are representative 
of two independent experiments arranged in triplicate. With few exceptions, the MIC of this strain 
ranged from 0.1 mg·mL−1, to 0.02 mg·mL−1 for TEOMS extracted in July and August, and 0.1 to  
0.2 mg·mL−1 for TEOMS extracted in September, and, in all cases, the extracts showing an interesting 
antifungal activity were in the first three hours of extraction. For the TEOMS extracted from six to  
24 h, the MIC values ranged from 6.25 to 12.5 mg·mL−1. TEOMS extracted in the first 3 h showed good 
antifungal activities, and in one particular case, extract A2h (Supplemental Material Figure S2 and Table 3), 
the anticandida activity was comparable to that of miconazole (Table 5 and Supplemental Material  
Table S1) [30], a well-known marketed antifungal synthetic drug. Analysis of results in Tables 3–6 clearly 
indicates that PO is very likely the chemical components responsible for the antifungal activities reported 
in Table 6. In fact, the most active mixtures are those containing higher PO percentages. Decreasing of 
the PO% led to lower active TEOMS except for the most complex mixture S24h where the antifungal 
activity is only about two times lower than J1h (highest PO%) and about seven times lower than A2h, the 
highest active TEOMS. Inspecting PO%, it is clear that it is not the only important constituent, and likely 
other minor chemicals are endowed with microbiological activities and may co-participate in the inhibition 
process with some synergistic mechanism similar to that reported recently by us [31,32]. The S24h (Table 4 
and Supplemental Material Figure S3) chemical complexity could explain the low micromolar antifungal 
activity (Supplemental Material Table S1) and is somehow in agreement with the phytocomplex 
hypothesis reported in many other experimental observations [33,34]. Further analysis of data in Table 6 
indicates the lack of any correlation between the antimicrobial activity and the cultivation stage of the 
plant, thus supporting the previous reported data that PO is mainly responsible for the antimicrobial 
activity. Somehow, this is in contrast with some bibliographic data reporting that EOs obtained during 
flowering season of a plant exhibit the most significant antimicrobial activity [26,35,36]. 
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Table 5. Anti-Candida albicans activities of the 18 TEOMS extracts. 
Sample 1 MIC mg·mL−1 PO % 
J1h 0.10 87.25 
J2h 0.10 70.59 
J3h 0.10 65.56 
J6h 6.25 26.03 
J12h 6.25 14.78 
J24h 12.50 - 
A1h 0.10 65.05 
A2h 0.02 77.51 
A3h 0.10 50.01 
A6h 0.78 16.90 
A12h 3.12 2.43 
A24h 6.25 - 
S1h 0.20 38.69 
S2h 0.20 35.64 
S3h 0.10 69.52 
S6h 6.25 13.20 
S12h 6.25 5.53 
S24h 0.20 5.61 
Miconazole 0.016  
1 Samples names were obtained by merging the month first letter and extraction time as reported in Table 1. 
2.4. Mutagenicity Test 
The mutagenicity assays were carried out on three TEOMS samples, namely J1h, A1h and S1h, being 
the most abundant and showing the strongest antimicrobial activities against Candida albicans. The 
three samples were firstly assayed for their cytotoxicity in the strains tested and were found to be not 
cytotoxic up to 400 μg·plate−1 (J1h), 50 μg·plate−1 (A1h) and 100 μg·plate−1 (S1h), respectively (Table 6). 
The presence of the metabolic activator S9 seemed to reduce the cytotoxicity of all three samples (Table 6). 
The cytotoxicity profile could be due to the different compositions of the three samples. In particular, 
J1h appeared to be the less toxic one; in contrast, A1h exerted the highest cytotoxicity in TA100. 
Based on these results, we carried out the mutagenicity test using concentrations lower than that found 
in the preliminary test (viz. J1h, 10 to 350 for all strains; A1h and S1h, 10 to 150 μg·plate−1 for TA98 and 
WP2uvrA, and 10 to 50 μg·plate−1 for TA100). In the absence of the metabolic activation system, the 
samples of TEOMS did not produce any increase in the number of revertant colonies for S. typhimurium 
TA98 and TA100 and in E. coli WP2uvrA, so resulting in them not being mutagenic. Likewise, no 
mutagenic effects were observed in the presence of S9; these results allow hypothesizing that no 
genotoxic derivatives were produced from the CYP450-mediated biotransformation of the TEOMS 
components (Table 8). Conversely, the reference mutagens, 2NF, 2AA, SA and MMS increased the 
number of revertant colonies about four to eight times with respect to the vehicle control, showing the 
suitability of the system to detect a genotoxic effect (Table 7). 
Present results highlight that the three samples of TEOMS, carrying a different phytochemical 
composition, exhibited a similar marked antimicrobial activity without inducing mutagenic effects. 
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Overall, the phytocomplex contained in the TEOMS samples appears not to be mutagenic, although the 
toxicity of each component is not always investigated. In this context, it should be underlined the 
presence of some compounds, including β-caryophyllene oxide, d-limonene and eucalyptol, known to 
possess genoprotective properties [37–40]. It could be argued that for sample A1h (Table 6) the number 
of revertants could be too low. Nevertheless, the number of revertants “0.3 ± 0.2 **t” for sample A1h, 
at the concentration of 850 μg·plate−1 makes sense: its low value stems from the fact that, at this 
concentration, A1h is toxic, as indicated by the symbol “t”. The toxicity causes a reduction of the number 
of revertant colonies with respect to the negative control (vehicle DMSO, Table 6). For the same reason, in 
the mutagenicity test (Table 7), the higher concentration used of 150 µg·plate−l did not show cytotoxicity 
and did not reduce the number of revertant colonies. 
Table 6. Cytotoxicity of J1h, A1h, and S1h samples from Mentha suaveolens essential oil 
on Salmonella ser. typhimurium TA98 and TA100 and of Escherichia coli WP2uvrA strains, 
in the absence and presence of the metabolic activator S9 (means ± SEM; n = 9 plates). 
Sample 
Compound 
Amount 
(μg·plate−1) 
Number of Revertant Colonies 
TA98 TA100 WP2uvrA 
−S9 +S9 −S9 +S9 −S9 +S9 
J1h 
50 44.0 ± 1.1 59.3 ± 1.8 153.3 ± 10.9 162.3 ± 2.6 48.2 ± 3.4 50.0 ± 2.5 
100 45.2 ± 2.1 53.7 ± 3.5 162.8 ± 10.2 149.2 ± 7.1 42.0 ±6.8 67.0 ± 3.7 
250 43.7 ± 3.3 58.8 ± 3.7 146.7 ± 8.3 152.0 ± 8.3 38.3 ± 1.8 58.8 ± 11.9 
400 38.0 ± 3.0 62.7 ± 6.3 136.0 ± 8.3 149.3 ± 3.2 44.2 ± 2.8 63.7 ± 3.7 
550 29.7 ± 3.4 **,t 56.5 ± 6.7 73.7 ± 11.2 **,t 129.7 ± 5.4 32.5 ± 5.0 ~t 57.2 ± 6.8 
850 15.0 ± 1.1 **,t 30.3 ± 2.8 **,t 40.0 ± 10.6 **,t 97.0 ± 2.3 **,t 19.3 ± 3.7 **,t 34.7 ± 6.7 **,t 
A1h 
50 49.3 ± 3.8 68.0 ± 7.9 144.0 ± 14.0 133.3 ± 23.6 42.7 ± 3.5 77.3 ± 5.8 
100 41.3 ± 3.5 60.7 ± 7.3 90.7 ± 14.3 **,t 127.3 ± 12.6 43.1 ± 4.9 74.7 ± 13.2 
250 41.3 ± 3.5 **,t 60.0 ± 7.3 73.3 ± 32.8 **,t 124.0 ± 16.1 ~t 32.0 ± 4.8 **,t 77.3 ± 1.3 
400 32.7 ± 4.3 **,t 30.4 ± 4.5 **,t 79.3 ± 7.4 **,t 106.7 ± 3.1 **,t 25.3 ± 3.3 **,t 57.3 ± 11.9 **,t 
550 25.3 ± 3.4 **,t 28.7 ± 9.4 **,t 64.0 ± 16.5 **,t 104.7 ± 8.3 **,t 30.7 ± 3.4 **,t 28.7 ± 2.8 **,t 
850 0.3 ± 0.2 **,t 0.5 ± 0.1 **,t 11.3 ± 5.2 **,t 111.3 ± 8.7 **,t 2.1 ± 0.1 **,t 12.1 ± 0.5 **,t 
S1h 
50 53.3 ± 1.3 54.7 ± 8.1 153.3 ± 4.8 177.3 ± 7.4 59.3 ± 5.9 58.2 ± 3.4 
100 54.0 ± 7.5 50.2 ± 6.7 153.3 ± 9.8 173.3 ± 13.3 50.7 ± 4.3 58.0 ± 5.0 
250 40.0 ± 2.3 **,t 61.3 ± 7.1 139.3 ± 9.9 **,t 170.7 ± 9.3 49.3±6.1 ~t 54.2 ± 2.8 
400 53.3 ± 3.5 **,t 56.7 ± 4.8 **,t 138.7 ± 6.4 **,t 146.0 ± 13.6 ~t 46.0 ± 5.2 ~t 52.0 ± 3.1 ~t 
550 17.3 ± 7.4 **,t 38.7 ± 9.3 **,t 117.3 ± 8.6 **,t 150.7 ± 10.7 **,t 44.7 ± 8.5 **,t 38.0 ± 2.3 **,t 
850 5.1 ± 0.3 **,t 11.8 ± 0.6 **,t 37.3 ± 12.5 **,t 49.3 ± 13.8 **,t 22.1 ± 1.3 **,t 17.8 ± 0.9 **,t 
Vehicle  43.3 ± 2.8 a 49.3 ± 2.1 a 143.2 ± 13.6 a 153.6 ± 17.1 a 45.9 ± 5.2 a 59.7 ± 5.3 a 
Mutagen  128.1 ± 8.1 b 186.1 ± 15.1 c 608.5 ± 14.9 d  379.2 ± 23.5 c  287.4 ± 17.2 e 323.7 ± 20.4 f 
t Toxicity (evaluated as >70% reduction of the number of revertant colonies vs. vehicle); ~t Minor toxicity 
(evaluated as a change in the auxotrophic background growth vs. vehicle). a DMSO 50 µL; b 2-Nitrofluorene 
(2 μg·plate−1); c 2-Aminoanthracene (1 μg·plate−1); d Sodium azide (1 μg·plate−1); e Methyl methane sulfonate 
(500 μg·plate−1); f 2-Aminoanthracene (10 μg·plate−1); ** p < 0.01 vs. vehicle (Anova + Dunnett’s multiple 
comparison post-test).  
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Table 7. Effect of J1h, A1h, and S1h samples from Mentha suaveolens essential oil on the 
number of spontaneous revertant colonies of Salmonella ser. typhimurium TA98 and TA100 
and of Escherichia coli WP2uvrA strains, in the absence and presence of the metabolic 
activator S9 (means ± SEM; n = 9 plates). 
Sample 
Compound 
Amount 
(μg·plate−1) 
Number of Revertant Colonies 
TA98 TA100 WP2uvrA 
−S9 +S9 −S9 +S9 −S9 +S9 
J1h 
10 46.0 ± 2.3 59.0 ± 3.2 133.3 ± 14.8 150.5 ± 15.4 49.3 ± 7.4 60.0 ± 2.3 
50 44.0 ± 1.1 59.3 ± 1.8 146.7 ± 8.3 129.7 ± 5.4 48.2 ± 3.4 50.0 ± 2.5 
100 38.0 ± 3.0 53.7 ± 3.5 162.8 ± 10.2 149.2 ± 7.1 39.5 ± 5.0 67.0 ± 3.7 
150 40.0 ± 1.8 55.7 ± 6.4 163.3 ± 11.8 155.3 ± 2.4 38.0 ± 5.0 60.2 ± 5.4 
250 43.7 ± 3.3 58.8 ± 3.7 136.0 ± 8.3 152.0 ± 8.3 38.3 ± 1.8 58.8 ± 11.9 
350 45.2 ± 2.1 62.7 ± 6.3 153.3 ± 10.9 149.3 ± 3.2 44.2 ± 2.8 63.7 ± 3.7 
A1h 
10 (10) 55.1 ± 6.8 48.9 ± 5.2 134.4 ± 13.2 140.8 ± 19.7 52.0 ± 5.4 65.8 ± 7.2 
50 (18) 49.3 ± 3.8 68.0 ± 7.9 144.0 ± 14.0 133.3 ± 23.6 42.7 ± 3.5 77.3 ± 5.8 
75 (25) 42.7 ± 3.7 62.0 ± 3.1 160.8 ± 14.3 130.0 ± 18.2 45.3 ± 5.3 59.0 ± 9.2 
100 (36) 41.3 ± 3.5 60.7 ± 7.3 170.0 ± 11.5 148.0 ± 4.6 43.1 ± 4.9 74.7 ± 13.2 
150 (50) 56.0 ± 11.1 60.0 ± 7.3 155.1 ± 8.8 155.6 ± 10.4 35.3 ± 1.6 68.0 ± 12.9 
S1h 
10 (10) 56.7 ± 6.8 64.0 ± 4.2 178.0 ± 13.1 138.0 ± 8.2 53.5 ± 3.6 59.3 ± 7.4 
50 (18) 53.3 ± 1.3 64.7 ± 8.1 153.3 ± 4.8 177.3 ± 7.4 59.3 ± 5.9 58.2 ± 3.4 
75 (25) 64.0 ± 7.7 70.2 ± 4.3 177.3 ± 12.7 145.5 ± 10.3 54.2 ± 4.3 59.5 ± 3.7 
100 (36) 64.0 ± 7.5 70.2 ± 6.7 168.3 ± 3.8 169.7 ± 17.8 50.7 ± 4.3 58.0 ± 5.0 
150 (50) 61.3 ± 5.8 68.0 ± 4.9 155.3 ± 14.4 146.7 ± 6.7 52.0 ± 9.2 58.5 ± 1.4 
Vehicle  47.7 ± 2.5 a 52.7 ± 2.7 a 157.1 ± 8.1 a 153.6 ± 17.1 a 48.2 ± 3.2 a 66.5 ± 3.9 a 
Mutagen  149.7 ± 10.6 b,** 266.1 ± 25.1 c,** 995.8 ± 85.9 d,** 379.2 ± 23.5 c,** 323.4 ± 31.2 e,** 347.4 ± 16.4 f,** 
a DMSO 50 µL; b 2-Nitrofluorene (2 μg·plate−1); c 2-Aminoanthracene (1 μg·plate−1); d Sodium azide  
(1 μg·plate−1); e Methyl methane sulfonate (500 μg·plate−1); f 2-Aminoanthracene (10 μg·plate−1). ** p < 0.01 
vs. vehicle (Anova + Dunnett’s multiple comparison post-test). 
3. Experiment Section 
3.1. Plant Material 
Aerial parts of MS were collected in a wild area about 10 Km from Tarquinia city (Viterbo, Italy, 
latitude 42°20'23.3406", longitude 11°46'16.3452", Supplemental Material Figure S4) in three different 
days (7 July, 24 August and 28 September 2011). Since every year the MS field is completely ploughed, 
the age of the plants was less than one year.  
3.2. Essential Oil Extractions 
Fresh aerial parts of the plant material (about 2.5 kg) were subjected to hydrodistillation using a  
62 L steel distillator apparatus (Albrigi Luigi E0131, Verona, Italy) separating oils at interval time of 1, 
2, 3, 6, 12 and 24 h. At each interval, the accumulated oil/water double phase (50 mL) was extracted 
three times with diethyl ether (20 mL). The organic layers were then dried on anhydrous Na2SO4, filtered 
and private of the solvent in vacuo to furnish pale yellow oils. 
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3.3. Essential Oil Analysis 
GC/MS conditions. The gas chromatographic/mass spectrometric (GC/MS) analysis was carried out 
with a GC-MS and GC-FID by using a turbomass Clarus 500 GC-MS/GC-FID from Perkin Elmer 
instruments (Waltham, MA, USA). A Stabilwax fused-silica capillary column (Restek, Bellefonte, PA, 
USA) (60 m × 0.25 mm, 0.25 mm film thickness) was used with helium as carrier gas (1.0 mL·min−1). 
GC oven temperature was kept at 60 °C for 5 min and programmed to 220 °C at a rate of 5 °C·min−1, 
and kept constant at 220 °C for 30 min. Solvent delay 0–2 min. and scan time 0.2 s. MS was taken at 70 eV. 
Mass range was from 30 to 350 m/z. 1 μL of the extract was diluted in 1 mL of methanol and 1 μL of the 
solution was injected into the GC injector at the temperature of 280 °C.  
The main components of essential oils were identified at first by GC injection of analytical standard 
compounds comparing their retention times with those obtained in the essential oil analysis. A second 
confirmation was performed by GC-MS by comparison of the mass spectra with those characteristic  
of the standard sample and, if not commercially available, with the NIST and NBS Libraries 
(https://library.nist.gov/). Relative abundances of the separated components were derived by using the 
same instrumentation with the FID detector configuration. 
3.4. Antimicrobial Assay  
The Minimum Inhibitory Concentration (MIC) was determined by micro-broth dilution method 
(microsterile plate) according to the Clinical and Laboratory Standards Institute/National Committee for 
Clinical Laboratory Standards (CLSI/NCCLS) Approved Standard M27-A3, 2008 [NCCLS]. The MIC 
was determined as the lowest concentration of drugs or essential oils at which no microbial growth was 
observed. Miconazole 0.5 mg·mL−1 solution was prepared dissolving the agent in endotoxin free water. 
Solutions of essential oil (100 mg·mL−1) were prepared in RPMI 1640. Briefly, to determine the MIC of 
TEOMS extracted at different times and in different months, or miconazole, RPMI-1640 supplemented 
with MOPS at pH 7 was used. TEOMS was diluted in RPMI-1640 supplemented with Tween 80  
(final concentration of 0.001% v/v). The dilutions, 11 increasing concentrations, ranging from 0.012 to 
12.48 mg·mL−1 of the essential oil, were prepared in 96 well plates. The inoculum size was about  
2.5 × 103 cells·mL−1. The plates were incubated at 30 °C for 24–48 h. 
3.5. Mutagenicity Tests 
Chemicals and S9-based metabolic activation system. All the substances used in the Ames test, 
including the mutagens 2-nitrofluorene (2NF) (CAS number 607-57-8; purity 98%), 2-aminoanthracene 
(2AA) (CAS number 613-13-8; purity 96%), sodium azide (SA) (CAS number 26628-22-8;  
purity > 99.5%), methyl methane sulfonate (MMS) (CAS number 66-27-3; purity 99%), and the media 
were obtained from Sigma-Aldrich Co (St. Louis, MO, USA). The TEOMS samples and the mutagens 
2NF and 2AA were dissolved in DMSO (CAS number 67-68-5; purity > 99.5%), while SA and MMS 
in deionised water.  
S9 fraction (the liver post mitochondrial supernatant of rats treated with the mixture phenobarbital/β-
naphthoflavone to induce the hepatic microsomal enzymes) was purchased from Moltox (Molecular 
Toxicology, Boone, NC, USA) and prepared just before use by adding: phosphate buffer (0.2 M)  
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500 µL, deionised water 130 µL, KCl (0.33 M) 100 µL, MgCl2 (0.1 M) 80 µL, S9 fraction 100 µL, 
glucose-6-phosphate (0.1 M) 50 µL and NADP (0.1 M) 40 µL. The final mixture was kept on ice  
during testing. 
Bacterial strains. Salmonella ser. typhimurium TA98 (hisD3052gal biochl1008rfa1001 uvrBpKM101), 
S. typhimurium TA100 (hisG56galbiochl1005rfa1004 ΔuvrB pKM101) and Eschericia coli WP2uvrA 
(trpE65ΔuvrA) were kindly supplied by the Research Toxicological Centre (Pomezia, Rome, Italy). The 
genotypes of these strains were confirmed by testing the presence of specific genetic markers, in 
preliminary Strain Check Assays [41]; thus, the permanent cultures were prepared and frozen. The working 
cultures, used in each experiment, were obtained from the frozen permanent cultures after incubation 
overnight (16 h) at 37 °C to reach a concentration of approximately 1 × 109 bacteria·mL−1. In each 
experiment, the number of viable cells for each strain was defined according to Di Sotto et al. [41]. 
Preliminary assays. Preliminarily, the solubility in the final treatment mixture of three samples of  
M. suaveolens essential oil was assessed, in order to find the highest concentration to use in the following 
assays. Insolubility was defined as the formation of a precipitate in the final mixture evident to unaided 
eye. All the samples did not give any precipitate up to the highest concentration tested of 850 μg·plate−1 
(corresponding to 320 μg·mL−1). Starting from this concentration, serial dilutions (dilution factor from 
1:1.2 to 1:2.5) was prepared and tested in the cytotoxicity assay. Cytotoxic effects were evaluated as a 
reduction (>70%) in the number of revertant colonies and as a change in the auxotrophic background 
growth (background lawn), in comparison with the control plates [41]. To perform the test, solutions of 
test substances (50 µL) were added to an overnight culture (100 µL) and S9 mixture or phosphate buffer 
(0.1 M; 500 µL). The mixture was pre-incubated under shaking at 37 °C for 30 min, then it was added 
with top agar (2 mL) containing 10% of histidine/biotin (0.5 mM) for TA98 and TA100, and 10% of 
tryptophan (0.5 mM) for WP2uvrA; finally it was poured onto a minimal agar plate. After incubation at 
37 °C for 48 h, the plates were examined, the background lawn was observed and the bacterial colonies 
were scored.  
Mutagenicity assays. Mutagenicity of the substances was assayed using the pre-incubation method [41]. 
Different dilutions (dilution factor from 1:1.2 to 1:1.5) of the three samples of OEMS were prepared 
starting from the highest non-toxic concentration. Therefore, their effect on the spontaneous revertant 
colonies of TA98, TA100 and WP2uvrA strains was tested in comparison with the vehicle (DMSO, 2% 
v/v; negative control). In each experiment, some plates treated with known mutagens (positive controls) 
were also included, in order to verify the ability of the experimental system to detect a genotoxic effect. 
As mutagens we used 2-nitrofluorene (2NF; 2 μg·plate−1 for TA98), sodium azide (SA; 1 μg·plate−1 for 
TA100) and methyl methanesulfonate (MMS; 500 μg·plate−1 for WP2uvrA), in the absence of the 
metabolic activator S9, while 2-aminoanthracene (2AA; 1 μg·plate−1 for TA98 and TA100 and  
10 μg·plate−1 for WP2uvrA) in the presence of S9. These concentrations of mutagens, obtained from the 
linear part of the concentration-response curve, were chosen as they increased the number of revertant 
colonies at least two-fold above the control value. The experiments were repeated at least twice and each 
concentration was tested in triplicate. To perform the test, an overnight culture (100 µL) was added to 
the solutions of the samples tested (50 µL) plus S9 mixture or phosphate buffer (0.1 M) (500 µL). The 
mixture was gently vortexed in a sterile tube then was incubated under shaking at 37 °C for 30 min. 
After the pre-incubation, the tubes were added with top agar (2 mL) containing 10% of histidine/biotin 
(0.5 mM) for TA98 and TA100, and 10% of tryptophan (0.5 mM) for WP2uvrA, then were gently 
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vortexed and poured onto a minimal agar plate. The plates were incubated at 37 °C for 72 h and then 
examined. The histidine- or tryptophan-independent revertant colonies and the viable cells were scored 
and the bacterial background lawn was observed. A positive response in the test was defined as an 
increase (at least two-fold above the control) in histidine- or tryptophan-independent revertant colonies 
in each strain [41]. 
Statistical analysis. All values are expressed as mean ± SE. The one-way analysis of variance  
(one-way ANOVA), followed by Dunnett’s multiple comparison post-test, was used to verify the 
significance of a positive response. A p value < 0.05 was considered statistically significant. Statistical 
analysis was performed with GraphPad Prism™ (Version 4.00) software (GraphPad Software, Inc.,  
San Diego, CA, USA). 
4. Conclusions 
In recent years, the interest in essential oils has continually increased; nevertheless, no detailed study 
on the extraction procedure has yet been reported considering both extraction time and period. In line 
with our previous studies on TEOMS, a systematic extraction procedure was applied to three different 
periods during the summer of 2011, and at various extraction times. In order to monitor the biological 
variability, the essential oils were assayed by means of a classical antimicrobial protocol that suggested 
piperitenone oxide as the principal active chemical constituent responsible for the antifungal activity. 
Although this was somewhat an expected result, the herein systematic procedure revealed that other 
constituents may participate actively in the biological effect. In particular, the extract S24h, although 
lacking piperitenone oxide, revealed a single digit micromolar activity (pMIC = 5.92, Supplemental 
Material Table S1) that can be mainly ascribed to the whole mixture where some of them act in a 
synergistic way and some act uncooperatively; as a matter of fact, sample A2h is five times more 
effective than sample J1h which contains less PO (compare their compositions in Tables 2, 3 and 5). It 
could be speculated that for A2h, α-cadinol and α-cubebene (the more abundant components after PO) 
could have some positive and additive biological role; on the other hand, for J1h it could be that  
α-pharnesene (the most abundant after PO) could demonstrate some anti-synergism with PO. The lack 
of mutagenic effect in the tested essential oils somewhat supports the safe use of Mentha suaveolens 
essential oil as a food additive. In conclusion, from data herein presented, the answers to the questions 
in the introduction can be partially answered. In relation to the biological activity, the period of extraction 
seems to be of marginal importance as any essential oil collected in the first three hours showed similar 
anti-candida activity and was deprived of any mutagenicity effects. On the other hand, consideration 
should also be given to the EO production yield or the chemical composition. Harvesting in August lead 
to the higher EO production, while in July the higher piperitenone oxide percentage was obtained. 
Regarding the second question (How long should the hydrodistillation time be?), the answer depends on 
what the study is conducted for. To obtain EOs with the highest PO content, hydrodistillation of 1 to 3 
must be undertaken, while for extraction of different components, like p-cymenene, cinerolone and 
demelverine, 24 h of hydrodistillation should be carried out. 
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